Free

How can we all make drug treatment safer?

Event Information

Share this event

Date and Time

Location

Location

Millennium Point

Curzon Street

Birmingham

B4 7XG

United Kingdom

View Map

Friends Who Are Going
Event description

Description

The Yellow Card Centre West Midlands is pleased to host a regional study day on safer drug treatment. In this session, we will explore:

  • New developments in pharmacovigilance
  • The use of appreciative inquiry to promote a positive drug safety culture
  • Awareness of adverse reactions to herbal medicine
  • The use of technology to enhance drug safety.


Attendees will receieve six CPD points from the Royal College of Physicians for attending the session.

Agenda

9.30 – 10am Refreshments and registration
10 -10.40am Peter Jeffries - Learning from Excellence
10.40 - 11.20am Sarah Pontefract – Does computerised prescribing save lives?
11.20 - 11.40am Refreshments
11.40am – 12.20pm Phil Tregunno - The use of social media to harness information about adverse drug reactions
12.20 - 1pm Jamie Hayes – The power of persuasion
1 - 2pm Lunch
2 - 2.40pm Dr Alastair Williamson - Human factors in the healthcare environment
2.40 - 3.20pm Professor Routledge - Improving the safety of herbal medicines
3.20 - 4pm Professor Robin Ferner– ADR Champions
4pm Refreshments and close

Speaker biographies

Sarah Pontefract, National Institute for Health Research (NIHR) Doctoral Research Fellow, Lecturer in Clinical Pharmacy and Therapeutics Editorial Lead, SCRIPT
Sarah is Doctoral Fellow of the NIHR and Lecturer in Clinical Pharmacy and Therapeutics. Her research interests focus on patient safety, specifically relating to medication errors, medicines optimisation and the use of electronic patient records. For her PhD, she is investigating the impact of electronic prescribing systems on pharmacist-physician communication in the hospital setting.

Professor Robin Ferner, Director of the West Midlands Centre for Adverse Drug Reactions
Robin is Director of the West Midlands Centre for Adverse Drug Reactions, a consultant physician and clinical pharmacologist in Birmingham and Honorary Professor at the University of Birmingham, where he has helped to teach the safe and rational use of medicines for more than 20 years. He now works part-time. He is the Royal College of Physicians member of the British Pharmacological Society–Royal College of Physicians Joint Specialist Committee on Clinical Pharmacology, has in the past been secretary of that committee and the BPS Clinical Subcommittee, and Chair of Specialist Training Committee. His research has focused on harm from medicines: adverse drug reactions, medication errors and poisoning. In 2012, he won the BPS Lilly Prize ‘For distinction in Clinical Pharmacology over many years’—a sign of longevity.

Phil Tregunno, Signal Management Unit Manager, MHRA’s Vigilance Intelligence and Research Group (VIRG), MHRA

Phil is the Signal Management Unit Manager within MHRA’s VIRG and has more than 13 years' of experience working in pharmacovigilance. For the past eight years, he has been responsible for leading and developing the Signal Management function, including systems, processes, and relevant aspects of pharmacovigilance legislation. Phil led the development of the MHRA’s proposal to lead the EU Innovative Medicines Initiative WEB-RADR project and subsequently co-ordinated the formation of the public consortium and its integration with the EFPIA consortium. Phil is now the project lead responsible for overall delivery of its objectives.

Professor Philip A Routledge, Clinical Professor, University of Newcastle
Philip graduated with a Bachelor’s degree in Medicine and Surgery (MB BS) in 1972 from the University of Newcastle, where later obtained his MD. He obtained Membership of the Royal College of Physicians in 1975, and was elected Fellow of the Royal Colleges of Physicians of London (1986), of Edinburgh (2002) and of the British Toxicological Society (2006). He was appointed OBE in the 2008 New Year's Honours List.

Phil joined the staff of the Department of Pharmacology at Newcastle University in 1975 as a research registrar. In 1977 he was awarded a Merck, Sharp and Dohme International Fellowship in Clinical Pharmacology and gained experience in Vanderbilt and Duke Universities, before being appointed Assistant Professor of Medicine (Medical Research) at Duke University in 1979. In 1980, he returned to the UK as Lecturer in Clinical Pharmacology at the University of Newcastle upon Tyne, before joining the University of Wales College of Medicine (now Cardiff University School of Medicine) as Senior Lecturer (1981). Reader (1986) and Professor (1989) of Clinical Pharmacology.

Jamie Hayes, Director at the All Wales Therapeutics and Toxicology Centre
Jamie is a pharmacist and Director at the All Wales Therapeutics and Toxicology Centre, an Honorary Senior Lecturer at the School of Medicine, Cardiff University and a Clinical Author for the Centre for Medicines Optimisation at Keele University. Jamie is also an executive coach and experienced medical educator, with particular interests in patient safety, behavioural change, decision making and influencing skills. He trained at the Welsh School of Pharmacy and qualified in 1992. His early career was as a clinical pharmacist at a number of hospitals in South Wales, with subsequent jobs taking him to New Zealand, North Wales and England, before finally returning to South Wales.

Peter Jeffries, Patient Safety Programme Manager, West Midlands Academic Health Science Network (WMAHSN)
Peter joined WMAHSN after working at Birmingham Children’s Hospital NHS Trust as the Chief Medical Officer’s Senior Projects Manager. He was part of the team at Birmingham Children’s Hospital working on safety in clinical handover as part of the Health Foundation’s Safer Clinical Systems Programme. He has worked in acute trusts in the West Midlands since 1997 in a number of roles, including in operational management, strategy and service improvement. Peter has managed a number of significant service improvement, quality and safety projects. As well as leading on patient safety for WMAHSN, he is also one of the first cohort of 250 Q members, who will be working on the co-design of the Q Initiative.

Dr Alastair Williamson, Consultant Anaesthetist, Heart of England NHS Foundation Trust (HEFT)
Alastair joined WMAHSN as an Associate Clinical Lead and is currently working for HEFT as a Consultant Anaesthetist. Alastair is mainly based at Good Hope Hospital and has worked in a number of different roles, including Clinical Site Lead and Associate Medical Director. He is also currently the Clinical Lead of TeamSTEPPS at HEFT. His skills include Lean and Six Sigma and he has applied Lean techniques to much of his work, especially in operating theatres.



Share with friends

Date and Time

Location

Millennium Point

Curzon Street

Birmingham

B4 7XG

United Kingdom

View Map

Save This Event

Event Saved